Innatus Therapeutics (shanghai) Co., Ltd.

This early-phase study tested the safety and tolerability of INT-210 capsules in 86 healthy adults aged 18-45. Researchers gave single and multiple doses, and also checked how food affects the drug. The goal was to gather safety data before testing in people with inflammatory bow…